← Back to catalogue
Research draft

hyperlipidemia

vr.tr.hyperlipidemia · XCT.STA

Let an agent explain hyperlipidemia and its types, relay causes, risk, screening and general management from cardiology and lipid guidelines, describe the forms the registry aliases name, and distinguish hyperlipidemia from dyslipidemia broadly, from atherosclerosis and from normal lipid variation, routing people to clinicians without personal advice.

Thing Registry Cross-cutting context

Research draft, second pass

A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.

written by Claude from model knowledge without web access - no source was read, every claim is a lead to verify

Researched by: Claude

Purpose and description

Let an agent explain hyperlipidemia and its types, relay causes, risk, screening and general management from cardiology and lipid guidelines, describe the forms the registry aliases name, and distinguish hyperlipidemia from dyslipidemia broadly, from atherosclerosis and from normal lipid variation, routing people to clinicians without personal advice.

Abnormally elevated levels of lipids or lipoproteins in the blood, including high LDL cholesterol, hypertriglyceridemia and major hypertriglyceridemia, mixed hyperlipidemia with both raised, familial forms such as familial hypercholesterolaemia and familial combined hyperlipidemia, and hyperalphalipoproteinemia with high HDL; the hypertriglyceridemic waist phenotype combines raised triglycerides with abdominal obesity. Hyperlipidemia is a major risk factor for cardiovascular disease, and very high triglycerides can cause pancreatitis. The model routes people to clinicians.

What it is for: Not applicable; a metabolic condition.

It can be explain types; relay risk and management; route to clinicians; distinguish related conditions.

Distinguishing features

Raised lipids

Genetic and acquired

Cardiovascular risk

Often silent

What it looks like

Not a visible object; sometimes xanthomas or corneal arcus.

Physical character

familial hypercholesterolaemia prevalence: about 1 in 250 note - heterozygous

severe hypertriglyceridemia threshold: about 10 mmol/L - about 880 mg/dL, pancreatitis risk

Fredrickson classification: types I to V note - 1967

How it is recognised

Elevated blood lipids or lipoproteins

Hypertriglyceridemia, familial hyperlipidemia, mixed hyperlipidemia, hyperalphalipoproteinemia, hypertriglyceridemic waist

Dyslipidemia includes low HDL; atherosclerosis is arterial disease; normal variation is within reference ranges

Related models

is a kind of - in registry terms

lipid metabolism disorder

increases risk of -

atherosclerosis

includes -

familial hypercholesterolemia

is treated with - among other therapies

statin

In practice

Families and kinds

hypercholesterolaemia including familial forms

hypertriglyceridemia and major hypertriglyceridemia

mixed and familial combined hyperlipidemia

hyperalphalipoproteinemia

secondary hyperlipidemia from diabetes, hypothyroidism or drugs

hypertriglyceridemic waist phenotype

Identifiers

ICD-10 E78 disorders of lipoprotein metabolism

MeSH D006949 Hyperlipidemias

Standards and regulation

ESC/EAS and ACC/AHA lipid guidelines

Screening programmes for familial hypercholesterolaemia

Failure modes and hazards

Agents giving personal medical or medication advice

Missing familial forms in young people

Pancreatitis from very high triglycerides

Also called

hypertriglyceridemiafamilial hyperlipidemiamixed hyperlipidemiahyperalphalipoproteinemiahypertriglyceridemic waistmajor hypertriglyceridemia

Where this came from

wikidata · CC0 1.0

Drafted structure

Bundle to layer to finding to question, as the second pass will find it: 4 bundles · 8 layers · 8 findings · 16 questions.

Understand What hyperlipidemia is.

Clinical.

Definition

Definition.

Definition

Definition.

  1. What is hyperlipidemia, and how does it differ from dyslipidemia, atherosclerosis and normal variation? definition
  2. Is the user asking about their own lipid results or medication, which needs a clinician? boundary

Types

Types.

Types

Types.

  1. What are hypertriglyceridemia, familial and mixed hyperlipidemia, hyperalphalipoproteinemia and the hypertriglyceridemic waist? definition
  2. Which entry fits the specific type? action
Causes Causes and risk.

Clinical.

Genetic

Genetic causes.

Genetic

Genetic.

  1. Which genes cause familial hyperlipidemias? provenance
  2. Which references are standard? provenance

Risk

Cardiovascular risk.

Risk

Risk.

  1. How do lipids affect cardiovascular risk, as guidelines describe? provenance
  2. Which sources are cited? provenance
Care Screening and management.

Clinical.

Screening

Screening.

Screening

Screening.

  1. How are lipids measured and when is screening recommended? provenance
  2. Which entry fits lipid profile? action

Management

Management.

Management

Management.

  1. What general approaches do guidelines describe, from lifestyle to statins and newer drugs? provenance
  2. Which entry fits statin? action
Context Classification and research.

Context.

Classification

Classification.

Classification

Classification.

  1. What is the Fredrickson classification? provenance
  2. Which entry fits Fredrickson classification? action

Research

Research.

Research

Research.

  1. What therapies are being researched, such as PCSK9 and ANGPTL3 targeting? provenance
  2. Which entry fits PCSK9 inhibitor? action

What the second pass must settle

  • Should hypertriglyceridemia and familial hypercholesterolaemia be separate primary entries?
  • How should lipid guidelines be linked?
  • The registry entry has merged aliases naming lipid patterns and a phenotype; should they be split off?